glycine has been researched along with Smoldering Multiple Myeloma in 1 studies
Smoldering Multiple Myeloma: An asymptomatic and slow-growing PLASMA CELL dyscrasia characterized by presence of MYELOMA PROTEINS and clonal bone marrow plasma cells without end-organ damage (e.g., renal impairment). It is distinguished from MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE by a much higher risk of progression to symptomatic MULTIPLE MYELOMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cespedes, DA | 1 |
| Gallitano, SM | 1 |
| Bhutani, D | 1 |
1 other study available for glycine and Smoldering Multiple Myeloma
| Article | Year |
|---|---|
Ixazomib as treatment for pyoderma gangrenosum associated with IgA smoldering multiple myeloma.
Topics: Aged; Antineoplastic Agents; Boron Compounds; Glycine; Humans; Immunoglobulin A; Male; Pyoderma Gang | 2022 |